Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5842600 | Life Sciences | 2012 | 8 Pages |
Abstract
Montelukast has ameliorated I/R induced vasculitic neuropathic pain, these effects may be due to inhibition of lipid peroxidation, reduction of oxidative stress, release of inflammatory mediators and neuroprotective actions. Hence, it could be used as a novel therapeutic agent for the management of vasculitic inflammation related neuropathic pain.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Arunachalam Muthuraman, Muthusamy Ramesh, Shailja Sood,